Polymorphism in the Alpha Cardiac Muscle Actin 1 Gene Is Associated to Susceptibility to Chronic Inflammatory Cardiomyopathy

Carregando...
Imagem de Miniatura
Citações na Scopus
25
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
TEIXEIRA, Priscila Camilo
PISSETTI, Cristina Wide
SABA, Bruno
WANG, Lin Hui Tzu
DIAS, Fabricio
Citação
PLOS ONE, v.8, n.12, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Aims: Chagas disease, caused by the protozoan Trypanosoma cruzi is endemic in Latin America, and may lead to a life-threatening inflammatory dilated, chronic Chagas cardiomyopathy (CCC). One third of T. cruzi-infected individuals progress to CCC while the others remain asymptomatic (ASY). A possible genetic component to disease progression was suggested by familial aggregation of cases and the association of markers of innate and adaptive immunity genes with CCC development. Since mutations in multiple sarcomeric genes, including alpha-cardiac actin (ACTC1) have been involved in hereditary dilated cardiomyopathy, we investigated the involvement of the ACTC1 gene in CCC pathogenesis. Methods and Results: We conducted a proteomic and genetic study on a Brazilian study population. The genetic study was done on a main cohort including 118 seropositive asymptomatic subjects and 315 cases and the replication was done on 36 asymptomatic and 102 CCC cases. ACTC1 protein and mRNA levels were lower in myocardial tissue from patients with end-stage CCC than those found in hearts from organ donors. Genotyping a case-control cohort of CCC and ASY subjects for all informative single nucleotide polymorphism (SNP) in the ACTC1 gene identified rs640249 SNP, located at the 5' region, as associated to CCC. Associations are borderline after correction for multiple testing. Correlation and haplotype analysis led to the identification of a susceptibility haplotype. Functional assays have shown that the rs640249A/C polymorphism affects the binding of transcriptional factors in the promoter regions of the ACTC1 gene. Confirmation of the detected association on a larger independent replication cohort will be useful. Conclusions: Genetic variations at the ACTC1 gene may contribute to progression to chronic Chagas Cardiomyopathy among T. cruzi-infected patients, possibly by modulating transcription factor binding to ACTC1 promoter regions.
Palavras-chave
Referências
  1. Abel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523
  2. Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132
  3. Barretto A C, 1993, Arq Bras Cardiol, V60, P225
  4. BARRETTO ACP, 1986, AM HEART J, V111, P307, DOI 10.1016/0002-8703(86)90144-4
  5. Basquiera AL, 2003, HEART, V89, P1186, DOI 10.1136/heart.89.10.1186
  6. BEALL CJ, 1989, GENE DEV, V3, P131, DOI 10.1101/gad.3.2.131
  7. Bestetti RB, 1997, INT J CARDIOL, V60, P187, DOI 10.1016/S0167-5273(97)00083-1
  8. Bilate AM, 2008, J INFECT DIS, V198, P614, DOI 10.1086/590347
  9. Bilate AMB, 2003, MICROBES INFECT, V5, P1116, DOI 10.1016/j.micinf.2003.07.001
  10. Coura JR, 2007, MEM I OSWALDO CRUZ, V102, P113, DOI 10.1590/S0074-02762007000900018
  11. Cunha-Neto E, 2005, AM J PATHOL, V167, P305, DOI 10.1016/S0002-9440(10)62976-8
  12. Cunha-Neto E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000900032
  13. Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52
  14. LARANJA FS, 1956, CIRCULATION, V14, P1035
  15. Fae KC, 2000, MICROBES INFECT, V2, P745, DOI 10.1016/S1286-4579(00)00501-3
  16. Ferreira RC, 2003, MEM I OSWALDO CRUZ, V98, P407, DOI 10.1590/S0074-02762003000300021
  17. Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569
  18. Gregorio CC, 1997, CELL STRUCT FUNCT, V22, P191
  19. HIGUCHI MD, 1987, CLIN CARDIOL, V10, P665
  20. Isnard A, 2011, GENES IMMUN, V12, P31, DOI 10.1038/gene.2010.43
  21. Januzzi JL, 2013, J AM COLL CARDIOL, V61, P1507, DOI 10.1016/j.jacc.2013.01.039
  22. Jiang HK, 2010, CIRC J, V74, P2410, DOI 10.1253/circj.CJ-10-0234
  23. Jorge MT, 2003, ANN TROP MED PARASIT, V97, P139, DOI 10.1179/000349803235001561
  24. Kirchhoff LV, 2004, FRONT BIOSCI, V9, P706, DOI 10.2741/1255
  25. Knoll R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569628
  26. Kruger M, 2009, J MOL CELL CARDIOL, V46, P490, DOI 10.1016/j.yjmcc.2009.01.004
  27. Kubota T, 2000, CIRCULATION, V101, P2518
  28. LU MH, 1992, J CELL BIOL, V117, P1007, DOI 10.1083/jcb.117.5.1007
  29. MADY C, 1994, CIRCULATION, V90, P3098
  30. MARTIN UO, 1987, MEDICINA-BUENOS AIRE, V47, P159
  31. Mocelin AO, 2005, EUR J HEART FAIL, V7, P869, DOI 10.1016/j.ejheart.2004.10.014
  32. Nogueira LG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001867
  33. Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251
  34. Nyholt DR, 2005, HUM HERED, V60, P61, DOI 10.1159/000087919
  35. Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750
  36. Pulkki KJ, 1997, ANN MED, V29, P339, DOI 10.3109/07853899708999358
  37. Ramasawmy R, 2006, CLIN INFECT DIS, V43, P305, DOI 10.1086/505395
  38. Reddy VS, 2008, J CELL PHYSIOL, V215, P697, DOI 10.1002/jcp.21348
  39. Reifenberg K, 2007, AM J PATHOL, V171, P463, DOI 10.2353/ajpath.2007.060906
  40. Ribeirao M, 2000, PARASITE IMMUNOL, V22, P49, DOI 10.1046/j.1365-3024.2000.00260.x
  41. Riol-Blanco L, 2005, J IMMUNOL, V174, P4070
  42. Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103
  43. Salvatella R, 2007, MEM I OSWALDO CRUZ, V102, P39, DOI 10.1590/S0074-02762007005000105
  44. Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
  45. Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011
  46. Talvani A, 2004, CLIN INFECT DIS, V38, P943, DOI 10.1086/381892
  47. Teixeira MM, 2002, TRENDS PARASITOL, V18, P262, DOI 10.1016/S1471-4922(02)02283-3
  48. Teixeira PC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001205
  49. Teixeira PC, 2012, WORLD J CLIN INFECT, V2, P39, DOI 10.5495/WJCID.V2.I3.39
  50. Tostes S, 2005, INT J CARDIOL, V99, P233, DOI 10.1016/j.ijcard.2004.01.026
  51. van Veldhuisen DJ, 2013, J AM COLL CARDIOL, V61, P1498, DOI 10.1016/j.jacc.2012.12.044
  52. ZICKER F, 1990, AM J TROP MED HYG, V43, P498